Related references
Note: Only part of the references are listed.Detection limits of DNA copy number alterations in heterogeneous cell populations
Oscar Krijgsman et al.
CELLULAR ONCOLOGY (2013)
Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment
Joost S. Vermaat et al.
CLINICAL CANCER RESEARCH (2012)
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
Efsevia Vakiani et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer
Wigard P. Kloosterman et al.
GENOME BIOLOGY (2011)
CGHpower: exploring sample size calculations for chromosomal copy number experiments
Ilari Scheinin et al.
BMC BIOINFORMATICS (2010)
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain
D. E. Stange et al.
GUT (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
M. Koopman et al.
BRITISH JOURNAL OF CANCER (2009)
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Wennuan Liu et al.
NATURE MEDICINE (2009)
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations
Tineke E. Buffart et al.
GENES CHROMOSOMES & CANCER (2008)
Comparative lesion sequencing provides insights into tumor evolution
Sian Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers
Rebecca J. Leary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Miriam Koopman et al.
LANCET (2007)
CGHcall: calling aberrations for array CGH tumor profiles
Mark A. van de Wiel et al.
BIOINFORMATICS (2007)
Stage-specific alterations of the genorne, transcriptorne, and proteome during colorectal carcinogenesis
Jens K. Habermann et al.
GENES CHROMOSOMES & CANCER (2007)
Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
Chieu B. Diep et al.
MOLECULAR CANCER (2004)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
